Neuland Laboratories to meet investors in Hyderabad next week

Neuland Laboratories Limited will participate in a group analyst/institutional investor meeting on December 10, 2025. The company's management will hold a non-deal roadshow (NDR) with B&K Securities in Hyderabad. The meeting format will include both group sessions and one-on-one interactions with investors. This engagement aims to provide an opportunity for the company to discuss its operations and strategy with key financial stakeholders.

The announcement, dated December 6, 2025, was made in accordance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Neuland Laboratories also clarified that the schedule and participant list for the meeting are subject to change due to unforeseen exigencies.

This intimation was shared with both BSE Limited and The National Stock Exchange of India Ltd. Sarada Bhamidipati, company secretary, digitally signed the communication on December 6, 2025.